Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression

Fibroblast-like synoviocytes (FLS) play an essential role in the pathogenesis of chronic inflammatory diseases, such as rheumatoid arthritis. Paeonol (Pae) is a phenolic compound found in many traditional Chinese medicine remedies. However, the effects of Pae on TNF-alpha-stimulated FLS and the underlying molecular mechanism are unknown. In this study, we aimed to investigate the anti-proliferative and anti-inflammatory effect of Pae against activated FLS. Rheumatoid arthritis FLS (RA-FLS) were pre-treated with different doses (25, 50, and 100 A mu M) of Pae or miR-155 inhibitor for 30 min or transfected with miR-155 mimic, and then treated with 50 ng/mL of tumor necrosis factor alpha (TNF-alpha) for 1 h. Cells that were untreated served as control. At 24 h after drug pretreatment, the proliferation of FLS was detected using the MTT assay. The concentrations of interleukin IL-6 and IL-1 beta in cell culture supernatant were examined by enzyme-linked immunosorbent assay (ELISA), and mRNA levels of Foxo3 and miR-155 exression in FLS were quantified by reverse transcription-polymerase chain reaction (RT-PCR). Protein exppressions of forkhead box O3 (FOXO3), cyclin D1, and c-Myc were detected by Western Blot. TNF-alpha induced the proliferation of FLS, whereas Pae inhibited this proliferation in a dose-dependent manner. Pae attenuated TNF-alpha-induced production of IL-6 and IL-1 beta, and inhibited the expression of miR-155 in a dose-dependent manner. In addition, miR-155 inhibitor decreased TNF-alpha-induced proliferation of FLS, and attenuated TNF-alpha-induced production of IL-6 and IL-1 beta. In addition, pretreatment with different doses of Pae or miR-155 inhibitor markedly attenuated TNF-alpha-induced decrease in protein expression of FOXO3 in FLS. Mechanistic studies revealed FOXO3 as miR-155-5p direct target and inhibition of FOXO3 led to the abolishment of Pae protective effects. Paeonol protected against TNF-alpha-induced proliferation and cytokine release of FLS by decreasing the expression of miR-155 and upregulating its target FOXO3.